A definite FOXO6 inhibitor is not yet characterized but in silico studies have demonstrated the porfimer sodium to be a potential FOXO6 inhibitor that may suppress gastric cancer progression (Poleboyinaet al., 2023) (Table 1). This evidence concerns the gene FOXO6 and gastric cancer.